Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Colon Cancer Stage III
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 100 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04488159
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Jérôme Galon, PhD Laboratory of Integrative Cancer Immunology, INSERM, Cordeliers Research Center
Get Well Soon